Article
SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1
12 Oct 2023
Abstract excerpt
Breast cancer stem cells are mainly responsible for poor prognosis, especially in triple-negative breast cancer (TNBC). In a previous study, we demonstrated that ε-Sarcoglycan (SGCE), a type Ⅰ single-transmembrane protein, is a potential oncogene that promotes TNBC stemness by stabilizing EGFR. Here, we further found that SGCE depletion reduces breast cancer stem cells, partially through inhibiting the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
